HerniorrhaphyNCT02302222
The Management of Closed Surgical Incisions Resulting From Incisional Hernia Repair and/or Functional Panniculectomy Using the Prevena™ Customizable™ Dressing
A study testing Customizable Dressing with ActiV.A.C. Therapy Unit in people with Herniorrhaphy and Abdominoplasty, run by KCI USA, Inc at 2 sites in United States.
Trial summary
The goal of this study is to evaluate the impact of Customizable in the management of extensive closed surgical incisions for Subjects undergoing abdominal surgery for incisional hernia repair and/or functional panniculectomy as compared to SOC dressing, and to significantly reduce the SSC rate experienced by Subjects… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Herniorrhaphy, Abdominoplasty
- What is being tested?
- Customizable Dressing with ActiV.A.C. Therapy Unit
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 71 participants
- Where
- 2 sitesUnited States
- Study dates
- May 2015to 31 Jul 2017
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Pre-Operative Inclusion Criteria:
- an adult 18 years old or older of either gender
- able to provide their own informed consent
- will undergo:
- a functional panniculectomy with a transverse or a fleur-de-lis incision
- AND/OR -
- an incisional hernia repair with a vertical incision at least 20 cm in length and at least 10 cm of undermining on each side of the incision
- BMI equal to or greater than 30
- has maintained a stable weight for at least 3 months as determined by the Investigator (applies to post weight loss patients only)
- pre-operatively assessed to undergo a procedure with a CDC Wound Classification of:
- Class I (Clean): An uninfected operative wound in which no inflammation is encountered and the respiratory, alimentary, genital or uninfected urinary tract is not entered
- OR -
- Class II (Clean Contaminated): An operative wound in which the respiratory, alimentary, genital or uninfected urinary tract are entered under controlled conditions and without unusual contamination
- willing and able to return for all scheduled study visits
- if a female of child-bearing potential, must test negative on a urine pregnancy test
- if a female of child-bearing potential, must be willing to utilize an acceptable method of birth control (i.e. oral contraceptives, condom with spermicide, diaphragm with spermicide, implants, IUD, injections, vaginal rings, hormonal skin patch) for the duration of the study
Intra-Operative Inclusion Criteria:
- continues to meet all pre-operative inclusion criteria
- has undergone a Class I or II CDC Wound Classification procedure resulting in a closed surgical incision able to be covered completely by Customizable dressing
Pre-Operative Exclusion Criteria:
- has a systemic bacterial or fungal infection at the time of surgery for incisional hernia repair and/or functional panniculectomy
- has a remote-site skin infection at the time of surgery for incisional hernia repair or functional panniculectomy
- pre-operatively assessed to undergo a procedure with a CDC Wound Classification of:
- Class III (Contaminated): Open, fresh, accidental wounds, and/or major breaks in sterile technique or gross spillage from the gastrointestinal tract
- OR -
- Class IV (Dirty-Infected): Old traumatic wounds with retained devitalized tissue and those that involve existing clinical infection or perforated viscera
- will have a transverse or fleur-de-lis incision that extends beyond the flank area and requires moving the Subject from the supine position during surgery
- has a known allergy or hypersensitivity to silver, or drape materials that contain acrylic adhesives
- has participated in a clinical study within the past 30 days
- who, in the investigator's opinion, would have any clinically significant condition that would impair the Subject's ability to comply with the study procedures
Post-Operative Exclusion Criteria:
- found to meet any of the pre-operative exclusion criteria
- determined to have a CDC Wound Classification of:
- Class III (Contaminated): Open, fresh, accidental wounds, and/or major breaks in sterile technique or gross spillage from the gastrointestinal tract
- OR -
- Class IV (Dirty-Infected): Old traumatic wounds with retained devitalized tissue and those that involve existing clinical infection or perforated viscera
Trial locations and contacts
2 sites in 1 country.
United States2 sites
Medical Research Center
Miami, Florida, 33144
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213
About this study
The goal of this study is to evaluate the impact of Customizable in the management of extensive closed surgical incisions for Subjects undergoing abdominal surgery for incisional hernia repair and/or functional panniculectomy as compared to SOC dressing, and to significantly reduce the SSC rate experienced by Subjects receiving Customizable vs. SOC surgical incision dressing.
- Conditions
- Herniorrhaphy, Abdominoplasty
- Being tested
- Customizable Dressing with ActiV.A.C. Therapy Unit, Standard of Care Dressing
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Customizable Dressing with ActiV.A.C. Therapy UnitDevice
Standard of Care DressingDevice
| Study group | Role | What they receive |
|---|---|---|
| Standard of Care | Active comparator | dry sterile dressing/gauze and steristrips Receives: Device: Standard of Care Dressing |
| Customizable | Experimental | Prevena Customizable Dressing with ActiV.A.C. Therapy Unit Receives: Device: Customizable Dressing with ActiV.A.C. Therapy Unit |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of Participants With Surgical Site Complications
Surgical Site Complications:
- Dehiscence
- Surgical site infection (SSI)
Measured: Within 30 Days Post-Surgical Procedure
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Nov 2014 (estimated)
- Study startMay 2015
- Primary completion31 Jul 2017
- Study completion31 Jul 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for HerniorrhaphyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 71 participants (actual)
Sponsor and investigators
- Lead sponsor
- KCI USA, Inc
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02302222
- Sponsor's protocol ID
- AHS.2012.Customizable.01
- Status last verified
- Oct 2024
- First submitted
- 24 Nov 2014
- Last updated
- 16 Oct 2024
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Oct 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Management of Closed Surgical Incisions Resulting From Incisional Hernia Repair and/or Functional Panniculectomy Using the Prevena™ Customizable™ Dressing
- ClinicalTrials.gov ID
- NCT02302222
- Acronym / sponsor ID
- AHS.2012.Customizable.01
- Conditions
- Herniorrhaphy, Abdominoplasty
- Study type
- Interventional
- Recruitment status
- Terminated
- Enrolment
- 71 participants (actual)
- Lead sponsor
- KCI USA, IncIndustry (pharma, biotech, devices)
- Study start
- May 2015 (actual)
- Primary completion
- 31 Jul 2017 (actual)
- Study completion
- 31 Jul 2017 (actual)
- First posted
- 26 Nov 2014 (estimated)
- Results
- Posted 12 Dec 2018
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this study is to evaluate the impact of Customizable in the management of extensive closed surgical incisions for Subjects undergoing abdominal surgery for incisional hernia repair and/or functional panniculectomy as compared to SOC dressing, and to significantly reduce the SSC rate experienced by Subjects receiving Customizable vs. SOC surgical incision dressing.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Standard of Care | Active comparator | Device: Standard of Care Dressingdry sterile dressing/gauze and steristrips |
| Customizable | Experimental | Device: Customizable Dressing with ActiV.A.C. Therapy UnitPrevena Customizable Dressing with ActiV.A.C. Therapy Unit |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Customizable Dressing with ActiV.A.C. Therapy Unit | Device | Customizable |
| Standard of Care Dressing | Device | Standard of Care |
Primary outcome
Number of Participants With Surgical Site Complications
Time frame: Within 30 Days Post-Surgical Procedure
Surgical Site Complications: * Dehiscence * Surgical site infection (SSI)
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Oct 2024.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
Related trials for Herniorrhaphy
Recruiting
Permanent Versus Slowly Dissolving Stitches for Non-Mesh (Shouldice) Groin Hernia Repair
Inguinal Hernia
Recruiting
Duramesh Versus Minimally Invasive IPOM for High-Risk Umbilical Hernia Repairs
Umbilical Hernia, Ventral Hernia
Recruiting
Watchful Waiting Versus Immediate Repair for Occult Contralateral Inguinal Hernias.
Inguinal Hernia Bilateral, Inguinal Hernia Unilateral
Active, not recruitingObservational study
Assessment of GORE® SYNECOR Biomaterial in Focused Patient Populations and Long-Term Application
Hernia, Ventral, Hernia Incisional
Recruiting
Comparing Two Laparoscopic Techniques for Hernia Repair in Children
Inguinal Hernia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Customizable Dressing with ActiV.A.C. Therapy Unit in people with Herniorrhaphy and Abdominoplasty, run by KCI USA, Inc at 2 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 16 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 12 Dec 2018). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of Participants With Surgical Site Complications (time frame: Within 30 Days Post-Surgical Procedure). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2024.